Yayın:
Gemcitabine Plus Paclitaxel may be a Promising Chemotherapy Regimen for Metastatic Granular Cell Tumour

dc.contributor.authorKanat, O.
dc.contributor.authorYalcinkaya, U.
dc.contributor.authorAkbunar, T.
dc.contributor.authorKurt, E.
dc.contributor.authorEvrensel, T.
dc.contributor.authorManavoğlu, O.
dc.contributor.buuauthorKanat, O.
dc.contributor.buuauthorYALÇINKAYA, ÜLVİYE
dc.contributor.buuauthorAkbunar, T.
dc.contributor.buuauthorKurt, Ender
dc.contributor.buuauthorEVRENSEL, TÜRKKAN
dc.contributor.buuauthorManavoǧlu, Osman
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPatoloji Ana Bilim Dalı
dc.contributor.departmentNükleer Tıp Ana Bilim Dalı
dc.contributor.departmentTıbbi Onkoloji Ana Bilim Dalı
dc.contributor.orcid0009-0000-6166-4466
dc.contributor.scopusid6602187347
dc.contributor.scopusid6508300295
dc.contributor.scopusid6506964123
dc.contributor.scopusid7006207332
dc.contributor.scopusid6603942124
dc.contributor.scopusid6602587152
dc.date.accessioned2025-05-13T13:58:08Z
dc.date.issued2008-02-01
dc.identifier.doi10.1016/j.clon.2007.09.002
dc.identifier.endpage 96
dc.identifier.issn0936-6555
dc.identifier.issue1
dc.identifier.scopus2-s2.0-38149078111
dc.identifier.startpage93
dc.identifier.urihttps://hdl.handle.net/11452/52685
dc.identifier.volume20
dc.indexed.scopusScopus
dc.language.isoen
dc.relation.journalClinical Oncology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleGemcitabine Plus Paclitaxel may be a Promising Chemotherapy Regimen for Metastatic Granular Cell Tumour
dc.typeLetter
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/ Patoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/ Nükleer Tıp Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/ Tıbbi Onkoloji Ana Bilim Dalı
local.indexed.atScopus
relation.isAuthorOfPublication88cde6d8-7aff-42a7-8102-4847acdacd8b
relation.isAuthorOfPublicationeceff514-6af7-4c3b-a146-b77546565a6c
relation.isAuthorOfPublication.latestForDiscovery88cde6d8-7aff-42a7-8102-4847acdacd8b

Dosyalar